Wuppertal, Germany

Siegfried Linke


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Siegfried Linke in Polyether Compounds

Introduction

Siegfried Linke, based in Wuppertal, Germany, is a notable inventor recognized for his contributions in the field of polyether compounds. With a focus on chemical innovations, Linke's work primarily revolves around developing compounds that have significant medicinal applications. His advancements in this niche have positioned him as a valuable asset in the realm of pharmaceutical research.

Latest Patents

Siegfried Linke holds one patent titled "Polyether compounds, their production and their medicinal use." This invention describes polyethers with an average molecular weight ranging from 3000 to 5000, comprising 60 to 80% propylene oxide and 20 to 40% ethylene oxide. The patent also covers compositions that include these polyethers and outlines methods for utilizing them, particularly emphasizing their anti-lipidaemic effects, making them of great interest in therapeutic applications.

Career Highlights

Linke is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His role at Bayer has been instrumental in advancing research on polyether compounds, allowing for innovative solutions in medicine. His expertise and dedication contribute significantly to Bayer's mission to improve global health through science.

Collaborations

Throughout his career, Siegfried Linke has had the privilege to collaborate with esteemed professionals, including Mithat Mardin and Hans P Krause. These partnerships have fostered a dynamic exchange of ideas and expertise, enhancing the development and application of polyether compounds in the pharmaceutical industry.

Conclusion

Siegfried Linke's efforts in the innovation of polyether compounds are of considerable importance, offering potential therapeutic benefits that could impact numerous health conditions. His work exemplifies the critical intersection of chemistry and medicine, showcasing the power of innovation to drive advancements in healthcare. As he continues his journey in research and development, Linke remains a key figure in the exploration of medicinal polyethers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…